Список проголосовавших за комментарий " Radius Health target lowered to $66 at H.C. Wainwright (37.29)H.C. Wainwright lowers their RDUS tgt to $66 from $71, reiterates Buy. Firm notes Radius continues to make progress with its four product candidates. However, the 3 month extension to the albaloparatide PDUFA date, now June 30th, and the lack of clarity of the potential European partner and launch have led them to adjust their model and PT."